Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancers|May 21, 2020
Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall SurvivalHanane Mansouri, Lindsay B Alcaraz, Caroline Mollevi, et al.
Cancer Research|May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular CellsChristopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
International Journal of Cancer|November 8, 2022
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activityLindsay B Alcaraz, Aude Mallavialle, Caroline Mollevi, et al.
Plos One|August 23, 2012
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasionNina Fenouille, Mélanie Tichet, Maeva Dufies, et al.
British Journal of Pharmacology|November 29, 2023
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancerTimothée David, Aude Mallavialle, Julien Faget, et al.
Plos One|June 22, 2012
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionJane Muret, Meriem Hasmim, Izabela Stasik, et al.
EMBO Reports|February 6, 2023
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potentialKenji F Shoji, Elsa Bayet, Sabrina Leverrier-Penna, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
Nature Communications|May 1, 2015
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasisMélanie Tichet, Virginie Prod'Homme, Nina Fenouille, et al.
Cancer Research|March 18, 2020
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant MelanomaChristophe A Girard, Margaux Lecacheur, Rania Ben Jouira, et al.
Pageof 3